Fig. 15

Effect of the oral astaxanthin supplementation on the OXA1L gene expression of horse-derived PBMCs. Analysis of the OXA1L gene expression levels by qRT-PCR at day 0 (A), week 5 (B) and week 10 (C) in horse-derived PBMCs. CTRL, non-treated control; EXP, supplemented group. Graphs in the top row represent the average of all subjects, and graphs in the bottom row represent the values for each subject individually. Mean and standard deviation are given. Statistical significance is depicted as; * p-value < 0.05, ** p-value < 0.01, *** p-value < 0.001, **** p-value < 0.0001; ns, not significant.